Skinbiotherapeutics PLC
Skinbiotherapeutics PLC
Trading as: SkinBioTherapeutics
#09632164 • Active
B2cPhysical ProductSubscription
SkinBioTherapeutics is a life science company dedicated to advancing skin health through innovative probiotic solutions. Their proprietary technology, SkinBiotix®, focuses on enhancing skin conditions and overall microbiome health.
Founded: 10/06/2015
Industries: Other human health activities
Website: https://skinbiotherapeutics.com
Phone: Subscribe to view
Email: Subscribe to view
Location: Macclesfield
Products
- Axisbiotix-ps™ Gut-skin Health Supplement
Services
- Probiotic Food Supplements
Financial Snapshot
Last accounts made up to 30 June 2024
Next accounts due 31 December 2025 (7 months)
Cash in Bank £0.8m
↓ -39%
Turnover £1.23m
↑ 807%
EBITDA -£2.75m
↑ -6%
Gross Profit £0.7m
↑ 694%
Total Liabilities £1.8m
↑ 241%
Employees 15
↑ 36%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Manprit Singh Randhawa | Company Director | 01/06/2022 | British | 42 years |
| Danielle Bekker | Director | 27/04/2022 | British | 48 years |
| Stuart Ashman | Company Director | 18/04/2019 | British | 58 years |
| Catherine Denise Prescott | Company Director | 01/03/2017 | British | 64 years |
| Martin Braddock Hunt | Director | 03/10/2016 | British | 66 years |
Role:
Company Director
Appointed:
01/06/2022
Nationality:
British
Age:
42 years
Role:
Director
Appointed:
27/04/2022
Nationality:
British
Age:
48 years
Role:
Company Director
Appointed:
18/04/2019
Nationality:
British
Age:
58 years
Role:
Company Director
Appointed:
01/03/2017
Nationality:
British
Age:
64 years
Role:
Director
Appointed:
03/10/2016
Nationality:
British
Age:
66 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality | |
|---|---|---|---|---|
| No active PSCs found | ||||
No active PSCs found
Financial Accounts
| Jun 2024 | Jun 2023 | Jun 2022 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
No charges registered
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 02/05/2025 | Capital | Capital Allotment Shares | View (3 pages) |
| 08/04/2025 | Capital | Capital Allotment Shares | View (3 pages) |
| 01/04/2025 | Capital | Capital Allotment Shares | View (3 pages) |
| 26/02/2025 | Capital | Capital Allotment Shares | View (3 pages) |
| 07/01/2025 | Resolution | Resolution | View (3 pages) |
| 17/12/2024 | Accounts | Accounts With Accounts Type Group | View (60 pages) |
| 17/10/2024 | Capital | Capital Allotment Shares | View (3 pages) |